Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 24-May-23 5:54 PM View:  | Theravance Inc. (INVA) | 22-May-23 | Grant | 16,495 | -- | -- | 19% 88.21K to 104.71K | |
| 27-Apr-22 6:48 PM View: | Theravance Inc. (INVA) | 25-Apr-22 | Grant | 12,647 | -- | -- | 17% 75.56K to 88.21K | |
| 20-May-21 8:14 PM View: | Theravance Inc. (INVA) | 14-May-21 | Grant | 17,482 | -- | -- | 30% 58.08K to 75.56K | |
| 28-Apr-20 4:09 PM View: | Theravance Inc. (INVA) | 24-Apr-20 | Grant | 16,917 | -- | -- | 41% 41.16K to 58.08K | |
| 06-Jan-20 1:30 PM View: | Medicines Co. (MDCO) | 06-Jan-20 | Disposition | 7,429 | -- | -- | (100%) 7.43K to 0 | |
| 03-Jun-19 5:11 PM View: | Medicines Co. (MDCO) | 30-May-19 | Grant | 3,663 | -- | -- | 97% 3.77K to 7.43K | |
| 24-May-19 9:58 PM View: | Theravance Inc. (INVA) | 24-Apr-19 | Grant | 16,399 | -- | -- | 66% 24.77K to 41.16K | |
| 04-Jun-18 4:54 PM View: | Medicines Co. (MDCO) | 31-May-18 | Grant | 3,766 | -- | -- | 100% 0 to 3.77K | |
| 26-Apr-18 4:10 PM View: | Theravance Inc. (INVA) | 24-Apr-18 | Grant | 14,249 | -- | -- | 135% 10.52K to 24.77K | |
| 14-Feb-18 5:39 PM View: | Theravance Inc. (INVA) | 12-Feb-18 | Grant | 10,517 | -- | -- | 100% 0 to 10.52K | |
| 16-Feb-17 2:18 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 16-Feb-17 | Disposition | 55,508 | -- | -- | (100%) 55.51K to 0 | |
| 16-Feb-17 2:18 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 13-Feb-17 | Gift | 15,600 | -- | -- | (22%) 71.11K to 55.51K | |
| 01-Feb-17 4:56 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 31-Jan-17 | Grant | 18,008 | -- | -- | 34% 53.1K to 71.11K | |
| 03-Feb-16 4:50 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 01-Feb-16 | Grant | 12,500 | -- | -- | 31% 40.6K to 53.1K | |
| 04-Feb-15 4:37 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 31-Jan-15 | Grant | 12,500 | -- | -- | 44% 28.1K to 40.6K | |
| 15-Jan-15 4:30 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 14-Jan-15 | Market Purchase (Planned) | 1,300 | $6.25 | $8,125.00 | 5% 26.8K to 28.1K | 281% |
| 15-Jan-15 4:30 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 13-Jan-15 | Market Purchase (Planned) | 1,300 | $6.97 | $9,061.00 | 5% 25.5K to 26.8K | 241% |
| 18-Dec-14 4:09 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 17-Dec-14 | Market Purchase (Planned) | 1,300 | $6.11 | $7,943.00 | 5% 24.2K to 25.5K | 290% |
| 18-Dec-14 4:09 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 16-Dec-14 | Market Purchase (Planned) | 1,300 | $6.07 | $7,891.00 | 6% 22.9K to 24.2K | 292% |
| 13-Nov-14 10:00 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 12-Nov-14 | Market Purchase (Planned) | 1,300 | $6.22 | $8,086.00 | 6% 21.6K to 22.9K | 283% |
| 13-Nov-14 10:00 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 11-Nov-14 | Market Purchase (Planned) | 1,300 | $6.30 | $8,190.00 | 6% 20.3K to 21.6K | 278% |
| 16-Oct-14 4:27 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 15-Oct-14 | Market Purchase (Planned) | 1,300 | $5.03 | $6,539.00 | 7% 19.0K to 20.3K | 373% |
| 16-Oct-14 4:27 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 14-Oct-14 | Market Purchase (Planned) | 1,300 | $5.07 | $6,591.00 | 7% 17.7K to 19.0K | 369% |
| 11-Sep-14 4:38 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 10-Sep-14 | Market Purchase (Planned) | 1,300 | $5.75 | $7,475.00 | 8% 16.4K to 17.7K | 314% |
| 11-Sep-14 4:38 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 09-Sep-14 | Market Purchase (Planned) | 1,300 | $5.93 | $7,709.00 | 9% 15.1K to 16.4K | 301% |
| 11-Sep-14 4:38 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 13-Aug-14 | Market Purchase (Planned) | 1,300 | $5.71 | $7,423.00 | 9% 13.8K to 15.1K | 317% |
| 11-Sep-14 4:38 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 12-Aug-14 | Market Purchase (Planned) | 1,300 | $5.52 | $7,176.00 | 10% 12.5K to 13.8K | 331% |
| 04-Feb-14 6:11 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 31-Jan-14 | Grant | 12,500 | -- | -- | 100% 0 to 12.5K |